Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab

被引：0
作者：
Michael A Postow
Diana M Cardona
Janis M Taube
Robert A Anders
Clive R Taylor
Jedd D Wolchok
Margaret K Callahan
Michael A Curran
Alexander M Lesokhin
Joseph F Grosso
Christine E Horak
John Cogswell
Jason S Simon
Ashok K Gupta
Mario Sznol
机构：
[1] Memorial Sloan-Kettering Cancer Center,Keck School of Medicine
[2] Duke University School of Medicine,undefined
[3] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,undefined
[4] University of Southern California,undefined
[5] Bristol-Myers Squibb,undefined
[6] Yale University School of Medicine and Yale Cancer Center,undefined
来源：
Journal of Translational Medicine | / 12卷 / Suppl 1期
关键词：
Ipilimumab; Tumor Infiltrate Lymphocyte; Advanced Melanoma; Myeloid Derive Suppressor Cell; Absolute Lymphocyte Count;
D O I：
10.1186/1479-5876-12-S1-O8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 30 条
  • [1] Topalian S(2012)Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366 2443-2454
  • [2] Hodi FS(undefined)undefined undefined undefined undefined-undefined
  • [3] Brahmer JR(undefined)undefined undefined undefined undefined-undefined
  • [4] Gettinger SN(undefined)undefined undefined undefined undefined-undefined
  • [5] Smith DC(undefined)undefined undefined undefined undefined-undefined
  • [6] McDermott DF(undefined)undefined undefined undefined undefined-undefined
  • [7] Powderly JD(undefined)undefined undefined undefined undefined-undefined
  • [8] Carvajal RD(undefined)undefined undefined undefined undefined-undefined
  • [9] Sosman JA(undefined)undefined undefined undefined undefined-undefined
  • [10] Atkins MB(undefined)undefined undefined undefined undefined-undefined
123